Lorenzo F. Fanchi
's-hertogenbosch, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Properties of CD8 T-cell-recognized neoantigens in different tumor types.
Journal: Immuno-oncology technology
Published: August 04, 2025
Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer.
Journal: JCO precision oncology
Published: November 01, 2020
The CMV-Specific CD8+ T Cell Response Is Dominated by Supra-Public Clonotypes with High Generation Probabilities.
Journal: Pathogens (Basel, Switzerland)
Published: May 31, 2020
Next-Generation Immunosequencing Reveals Pathological T-Cell Architecture in Autoimmune Hepatitis.
Journal: Hepatology (Baltimore, Md.)
Published: March 20, 2020
Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection.
Journal: Nature immunology
Published: September 29, 2019
Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.
Journal: Cancer immunology research
Published: June 22, 2019
T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors.
Journal: Oncoimmunology
Published: June 14, 2019
Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy.
Journal: Oncoimmunology
Published: June 12, 2018
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers.
Journal: Nature medicine
Published: May 08, 2018
Last Updated: 09/26/2026